Publications by authors named "I V Akushevich"

Background: Heart failure (HF) is a challenging clinical and public health problem characterized by high prevalence and mortality among US older adults, along with a recent decline in HF prevalence and increase in mortality. The changes of prevalence can be decomposed into pre-existing disease prevalence, disease incidence, and respective survival, while the changes of mortality can be decomposed into mortality in the general population independent from HF, pre-existing HF prevalence, incidence, and respective survival. These epidemiological components may contribute differently to the changes in prevalence and mortality.

View Article and Find Full Text PDF
Article Synopsis
  • Some research suggests that being overweight (BMI 25-30) might help older people live longer.
  • Scientists did a study using special DNA markers to find out if being overweight really affects how long someone lives.
  • They discovered that older adults who are overweight (ages 75-85) could live longer than those with normal weight.
View Article and Find Full Text PDF

Background: Elevated concentration of amyloids in the cerebrum results in elevated risks for cerebral hemorrhage and early AD onset following early depression/dementia onset. In this study, we compare patterns of amyloid depositions across eight regions of interest of the human brain between U.S.

View Article and Find Full Text PDF

Overweight, defined by a body mass index (BMI) between 25 and 30, has been associated with enhanced survival among older adults in some studies. However, whether being overweight is causally linked to longevity remains unclear. To investigate this, we conducted a Mendelian randomization (MR) study of lifespan 85+ years, using overweight as an exposure variable and data from the Health and Retirement Study and the Long Life Family Study.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease is a condition marked by cognitive and functional declines, and the study examined the effects of tilavonemab on these declines using the Clinical Dementia Rating (CDR) scale.
  • Researchers used longitudinal Item Response Theory (IRT) models to analyze changes in early-stage AD patients, finding that cognitive decline was faster than functional decline, and tilavonemab did not provide significant benefits.
  • The study highlighted a significant relationship between baseline severities and their progression rates, indicating that cognitive and functional declines in AD are interconnected, and suggested the usefulness of multidimensional IRT models for understanding disease progression.
View Article and Find Full Text PDF